Published on in Vol 10, No 10 (2021): October

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/29695, first published .
A New Tool for Safety Evaluation and a Combination of Measures for Efficacy Assessment of Cotransplanting Human Allogenic Neuronal Stem Cells and Mesenchymal Stem Cells for the Treatment of Parkinson Disease: Protocol for an Interventional Study

A New Tool for Safety Evaluation and a Combination of Measures for Efficacy Assessment of Cotransplanting Human Allogenic Neuronal Stem Cells and Mesenchymal Stem Cells for the Treatment of Parkinson Disease: Protocol for an Interventional Study

A New Tool for Safety Evaluation and a Combination of Measures for Efficacy Assessment of Cotransplanting Human Allogenic Neuronal Stem Cells and Mesenchymal Stem Cells for the Treatment of Parkinson Disease: Protocol for an Interventional Study

Fatima Jamali   1 , PhD ;   Mayis Aldughmi   2 , PhD ;   Mohammad W Khasawneh   1 , MD ;   Said Dahbour   3, 4 , MD ;   Alaa A Salameh   1 , MSc, PT ;   Abdalla Awidi   1, 5 , MD

1 Cell Therapy Center, University of Jordan, Amman, Jordan

2 Department of Physiotherapy, School of Rehabilitation Sciences, University of Jordan, Amman, Jordan

3 Medical Faculty, University of Jordan, Amman, Jordan

4 Neurology Division, Jordan University Hospital, Amman, Jordan

5 Hematology Department, Jordan University Hospital, Amman, Jordan

Corresponding Author: